Insulin Resistance in Patients with Acne Vulgaris

Acne vulgaris presents multifactorial pathogenesis, which may include insulin resistance. To investigate whether insulin resistance is a causative factor in acne vulgaris development, this cohort study and a systematic review were conducted. A cohort of 41 acne vulgaris patients and 47 healthy BMI-matched controls were recruited. Glucose and insulin fasting serum levels were obtained and the HOMA-IR was calculated; insulin resistance was diagnosed in cases with a HOMA-IR value over 2.1. The mean +/- SD values for glucose fasting serum level were as follows: 94.88 +/- 7.731 (mg/dL) in the study group and 79.51 +/- 7.175 (mg/dL) in the controls (p < 0.001). The mean +/- SD insulin fasting serum levels were 14.47 +/- 6.394 (mu IU/mL) and 11.83 +/- 4.309 (mu IU/mL) (p = 0.059), respectively. The HOMA-IR mean +/- SD value calculated for the study group was 3.4 +/- 1.49 and, in the control group, it was 2.34 +/- 0.909 (p < 0.001). Out of 41 patients, 32 were diagnosed with insulin resistance (78%), and 26 of the 47 controls were diagnosed with IR (55%) (p = 0.026). An insulin resistance diagnosis was statistically more common among the acne patients, compared to the controls. In the articles reviewed in this paper, insulin resistance was found to be more frequent in acne vulgaris patients. Both our study and the papers analyzed in the review indicate that insulin resistance might be an independent factor in acne vulgaris development and should be considered when diagnosing and treating acne.

Automated summary

Insulin resistance may play a role in the development of acne vulgaris, as indicated by this cohort study and systematic review. The findings suggest that insulin resistance is more common in acne vulgaris patients and should be considered as an independent factor in diagnosis and treatment.